Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Verena Schoenau et al.|The Lancet|2024Cited by 134
The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility StudyJulian Häger, Mario M. Zaiss, Holger Bang et al.|Nutrients|2019Cited by 134
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugsDavid Simón, Asmir Vodenčarević, Koray Taşçılar et al.|Arthritis Research & Therapy|2021Cited by 60
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Taşçılar, Jürgen Rech, Melanie Hagen et al.|The Lancet Rheumatology|2021Cited by 31
Towards a pro-resolving concept in systemic lupus erythematosusSebastian Boeltz, Martin Herrmann, Melanie Hagen et al.|Seminars in Immunopathology|2019Cited by 23